Active Implantable Medical Devices Market - Global Industry Analysis

Active Implantable Medical Devices Market By Product (Cardiac Pacemakers, Implantable Cardioverter Defibrillators (ICD), Nerve Simulators, Cochlear Implants, and Ventricular Assist Devices), By Application (Cardiovascular, Neurological, Hearing Impairment, and Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Published Date: 10-May-2022 Category: Medical Device Report Format : PDF Pages: 180 Report Code: ZMR-3371 Status : Published

The global active implantable medical devices market was worth around USD 85.31 billion in 2021 and is estimated to grow to about USD 143.10 billion by 2028, with a compound annual growth rate (CAGR) of approximately 6.60 percent over the forecast period.

Description

Industry Prospective:

The global active implantable medical devices market was worth around USD 85.31 billion in 2021 and is estimated to grow to about USD 143.10 billion by 2028, with a compound annual growth rate (CAGR) of approximately 6.60 percent over the forecast period. The report analyzes the active implantable medical devices market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the active implantable medical devices market.

Active Implantable Medical Devices Market: Overview

An Active Implantable Medical Device (AIMD) is a medical device that is implanted entirely or partially into the human body for therapeutic or diagnostic reasons and is meant to stay there. Neurostimulators, cochlear implants, ventricular assist systems & devices, infusion pumps, defibrillators, and pacemakers, are all examples of AIMDs.

COVID-19 Impact:

During the initial COVID-19 pandemic, there was a decrease in the number of patients admitted to hospitals for implant surgery. It was because individuals were afraid of becoming infected during the period of isolation and lockdown. Patients' admissions to hospitals were reduced in many locations, showing that several patients with moderate - to - severe disabilities skipped hospital visits. The net effect of COVID-19 on the implantable medical device sector has been reported to be adverse. The drop in demand for implant surgery was linked to this. Furthermore, since the number of patients admitted to hospitals for implant surgery has decreased, market participants have lowered their expenditure on raw materials and resources.

Active Implantable Medical Devices Market: Growth Drivers

Rising demand for active implantable medical devices is boosting the market growth

The need for active implantable devices has increased as the number of disorders and diseases has increased. These devices aid in the support or replacement of any injured bodily organs, as well as the enhancement and treatment of normal body functions. One of the most crucial aspects of patient care is an active implanted medical device. One of the key drivers of global active implantable medical device market growth is the increasing senior population. The functioning of numerous organs of the human body gradually deteriorates with age. As a result, for movement and other help, humans must rely on a variety of medical gadgets. As a result, implantable devices are in high demand. Adults are affected by chronic ailments such as heart disease and arthritis, among others. One of the most frequent joint disorders in the United States is osteoarthritis (OA). It's also known as degenerative joint disease, and it affects the hands, hips, and knees the most. As a result of the country's rising elderly population, demand for orthopedic implants and reconstructive joint replacement is predicted to rise. All these factors are fostering market growth.

Global Active Implantable Medical Devices Market

Active Implantable Medical Devices Market: Restraints

Device-related concerns to hinder the market growth.

Device-related concerns, such as network security and device failure, may impede market expansion. For instance, introducing a device into the human body may elicit an immune system from the surrounding tissues, resulting in performance deterioration, making long-term usage of these devices problematic. In addition to this, factors like less developed healthcare infrastructure in undeveloped countries, high cost of implants, and less awareness of medical devices in rural areas are restraining the market growth.

Active Implantable Medical Devices Market: Opportunities

Advancements in technology in the field of medical devices to boost the market during the forecast period.

Implantable medical devices are attracting more attention than ever before. Recently, the prospect of long-term and secure implantation in the human body without hazardous product release or device destruction by bodily fluids has appeared. Strengthening their portfolios and investing in technical improvements are two strategies used by device makers to increase revenue. Continuous advancements in electrode, packaging, microelectronics, and biomedical signal processing technology have fueled the development of active implantable medical devices (AIMDs) that transmit data and power through wireless telemetry. In addition to this, producers of AIMDs are making an investment in improving hydrolysis resistance, strength, implant stability, and radiolucency in MRIs, CT scans, & X-rays and the effects of ionizing radiation without imaging aberrations. All such factors are likely to create several opportunities for the global active implantable medical devices market growth during the forecast period.

Active Implantable Medical Devices Market: Challenges

Strict regulatory controls for medical devices to pose major challenge for the market growth

Active Implantable Medical Devices (AIMDs) are one of the most high-risk device types, requiring stringent regulatory oversight before reaching global markets. Both active implantable medical devices and their accessories are categorized as Class III, requiring the strictest regulatory control. Pre- and post-market, AIMDs are subject to stringent effective regulation. The MDR's regulatory requirements also apply to any accessories that are required for the device to function properly, including software programs, refill kits, programmers, leads, implant kits, controllers, and battery packs. Such strict regulations for AIMD pose a major challenge for the market expansion.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Active Implantable Medical Devices Market: Segmentation

The global active implantable medical devices market is divided based on product, application, end-user, and region. By product, the global market is segregated into ventricular assist devices, cochlear implants, nerve stimulators, implantable cardioverter defibrillators (ICD), and cardiac pacemakers. Based on the application, the market is split into hearing impairment, neurological, cardiovascular, and others. The end-user segment is classified into ambulatory surgical centers, specialty clinics, and hospitals.

Recent Developments

  • In February 2022, the FDA approved Abbott's CardioMEMSTM HF System which assists the patient with earlier-stage heart failure. Patients in the early stages of heart failure now have access to the CardioMEMSTM HF System, a tiny implanted sensor that can detect early warning signals of deteriorating heart failure.
  • In April 2022, BIOTRONIK received FDA approval for Renamic Neo, its futuristic programmer for implanted cardiac rhythm management devices including pacemakers, ICDs, and implantable cardiac monitors.

Active Implantable Medical Devices Market: Regional Landscape

North America to hold the major share in the global market

North America is expected to hold the largest share of the global active implantable medical devices market, and this is expected to continue during the forecast period. The expanding demand for neurological and cardiovascular problems, as well as a rising focus on the development of sophisticated and novel products, are expected to propel the North American market forward in the approaching years. Furthermore, rising healthcare expenditures and increased consumer awareness of the availability of effective treatments are expected to fuel market expansion in the near future. In addition, Asia Pacific is expected to increase at a steady pace over the projection period. Increasing elderly populations and the rising frequency of chronic diseases are two key factors that are expected to propel the Asia Pacific market.

Active Implantable Medical Devices Market: Competitive Landscape

The predominant players that are successfully functioning in the global active implantable medical devices market are Cardinal Health, Inc., C. R. Bard, Inc., Boston Scientific Corporation, Biotronik SE, and Co. KG, Abbott Laboratories, LivaNova PLC, Johnson and Johnson, Integra LifeSciences Holdings Corporation, Globus Medical, Inc., and CONMED Corporation, among others.

Global active implantable medical devices market is segmented as follows:

By Product

  • Cardiac Pacemakers
  • Implantable Cardioverter Defibrillators (ICD)
  • Nerve Simulators
  • Cochlear Implants
  • Ventricular Assist Devices

By Application

  • Cardiovascular
  • Neurological
  • Hearing impairment
  • Others

By End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Active Implantable Medical Devices Market, (2022 - 2028) (USD Billion)
    • 2.2 Global Active Implantable Medical Devices Market : snapshot
  • Chapter 3. Global Active Implantable Medical Devices Market - Industry Analysis
    • 3.1 Active Implantable Medical Devices Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Rising demand for active implantable medical devices is boosting the market growth
    • 3.3 Market Restraints
      • 3.3.1. Device-related concerns to hinder the market growth.
    • 3.4 Market Opportunities
      • 3.4.1. Advancements in technology in the field of medical devices to boost the market during the forecast period.
    • 3.5 Market Challenges
      • 3.5.1. Strict regulatory controls for medical devices to pose major challenge for the market growth
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Product
      • 3.7.2 Market attractiveness analysis By Ventricular Assist Devices
      • 3.7.3 Market attractiveness analysis By End User
  • Chapter 4. Global Active Implantable Medical Devices Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Active Implantable Medical Devices Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Active Implantable Medical Devices Market - Product Analysis
    • 5.1 Global Active Implantable Medical Devices Market overview: By Product
      • 5.1.1 Global Active Implantable Medical Devices Market share, By Product, 2021 and 2028
    • 5.2 Cardiac Pacemakers
      • 5.2.1 Global Active Implantable Medical Devices Market by Cardiac Pacemakers, 2022 - 2028 (USD Billion)
    • 5.3 Implantable Cardioverter Defibrillators (ICD)
      • 5.3.1 Global Active Implantable Medical Devices Market by Implantable Cardioverter Defibrillators (ICD), 2022 - 2028 (USD Billion)
    • 5.4 Nerve Simulators
      • 5.4.1 Global Active Implantable Medical Devices Market by Nerve Simulators, 2022 - 2028 (USD Billion)
    • 5.5 Cochlear Implants
      • 5.5.1 Global Active Implantable Medical Devices Market by Cochlear Implants, 2022 - 2028 (USD Billion)
    • 5.6 Ventricular Assist Devices
      • 5.6.1 Global Active Implantable Medical Devices Market by Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • Chapter 6. Global Active Implantable Medical Devices Market - Ventricular Assist Devices Analysis
    • 6.1 Global Active Implantable Medical Devices Market overview: By Ventricular Assist Devices
      • 6.1.1 Global Active Implantable Medical Devices Market share, By Ventricular Assist Devices, 2021 and 2028
    • 6.2 Cardiovascular
      • 6.2.1 Global Active Implantable Medical Devices Market by Cardiovascular, 2022 - 2028 (USD Billion)
    • 6.3 Neurological
      • 6.3.1 Global Active Implantable Medical Devices Market by Neurological, 2022 - 2028 (USD Billion)
    • 6.4 Hearing impairment
      • 6.4.1 Global Active Implantable Medical Devices Market by Hearing impairment, 2022 - 2028 (USD Billion)
    • 6.5 Others
      • 6.5.1 Global Active Implantable Medical Devices Market by Others, 2022 - 2028 (USD Billion)
  • Chapter 7. Global Active Implantable Medical Devices Market - End User Analysis
    • 7.1 Global Active Implantable Medical Devices Market overview: By End User
      • 7.1.1 Global Active Implantable Medical Devices Market share, By End User, 2021 and 2028
    • 7.2 Hospitals
      • 7.2.1 Global Active Implantable Medical Devices Market by Hospitals, 2022 - 2028 (USD Billion)
    • 7.3 Specialty Clinics
      • 7.3.1 Global Active Implantable Medical Devices Market by Specialty Clinics, 2022 - 2028 (USD Billion)
    • 7.4 Ambulatory Surgical Centers
      • 7.4.1 Global Active Implantable Medical Devices Market by Ambulatory Surgical Centers, 2022 - 2028 (USD Billion)
  • Chapter 8. Active Implantable Medical Devices Market - Regional Analysis
    • 8.1 Global Active Implantable Medical Devices Market Regional Overview
    • 8.2 Global Active Implantable Medical Devices Market Share, by Region, 2021 & 2028 (USD Billion)
    • 8.3. North America
      • 8.3.1 North America Active Implantable Medical Devices Market, 2022 - 2028 (USD Billion)
        • 8.3.1.1 North America Active Implantable Medical Devices Market, by Country, 2022 - 2028 (USD Billion)
    • 8.4 North America Active Implantable Medical Devices Market, by Product, 2022 - 2028
      • 8.4.1 North America Active Implantable Medical Devices Market, by Product, 2022 - 2028 (USD Billion)
    • 8.5 North America Active Implantable Medical Devices Market, by Ventricular Assist Devices, 2022 - 2028
      • 8.5.1 North America Active Implantable Medical Devices Market, by Ventricular Assist Devices, 2022 - 2028 (USD Billion)
    • 8.6 North America Active Implantable Medical Devices Market, by End User, 2022 - 2028
      • 8.6.1 North America Active Implantable Medical Devices Market, by End User, 2022 - 2028 (USD Billion)
    • 8.4. Europe
      • 8.4.2 Europe Active Implantable Medical Devices Market, 2022 - 2028 (USD Billion)
        • 8.4.2.1 Europe Active Implantable Medical Devices Market, by Country, 2022 - 2028 (USD Billion)
    • 8.4 Europe Active Implantable Medical Devices Market, by Product, 2022 - 2028
      • 8.4.1 Europe Active Implantable Medical Devices Market, by Product, 2022 - 2028 (USD Billion)
    • 8.5 Europe Active Implantable Medical Devices Market, by Ventricular Assist Devices, 2022 - 2028
      • 8.5.1 Europe Active Implantable Medical Devices Market, by Ventricular Assist Devices, 2022 - 2028 (USD Billion)
    • 8.6 Europe Active Implantable Medical Devices Market, by End User, 2022 - 2028
      • 8.6.1 Europe Active Implantable Medical Devices Market, by End User, 2022 - 2028 (USD Billion)
    • 8.5. Asia Pacific
      • 8.5.3 Asia Pacific Active Implantable Medical Devices Market, 2022 - 2028 (USD Billion)
        • 8.5.3.1 Asia Pacific Active Implantable Medical Devices Market, by Country, 2022 - 2028 (USD Billion)
    • 8.4 Asia Pacific Active Implantable Medical Devices Market, by Product, 2022 - 2028
      • 8.4.1 Asia Pacific Active Implantable Medical Devices Market, by Product, 2022 - 2028 (USD Billion)
    • 8.5 Asia Pacific Active Implantable Medical Devices Market, by Ventricular Assist Devices, 2022 - 2028
      • 8.5.1 Asia Pacific Active Implantable Medical Devices Market, by Ventricular Assist Devices, 2022 - 2028 (USD Billion)
    • 8.6 Asia Pacific Active Implantable Medical Devices Market, by End User, 2022 - 2028
      • 8.6.1 Asia Pacific Active Implantable Medical Devices Market, by End User, 2022 - 2028 (USD Billion)
    • 8.6. Latin America
      • 8.6.4 Latin America Active Implantable Medical Devices Market, 2022 - 2028 (USD Billion)
        • 8.6.4.1 Latin America Active Implantable Medical Devices Market, by Country, 2022 - 2028 (USD Billion)
    • 8.4 Latin America Active Implantable Medical Devices Market, by Product, 2022 - 2028
      • 8.4.1 Latin America Active Implantable Medical Devices Market, by Product, 2022 - 2028 (USD Billion)
    • 8.5 Latin America Active Implantable Medical Devices Market, by Ventricular Assist Devices, 2022 - 2028
      • 8.5.1 Latin America Active Implantable Medical Devices Market, by Ventricular Assist Devices, 2022 - 2028 (USD Billion)
    • 8.6 Latin America Active Implantable Medical Devices Market, by End User, 2022 - 2028
      • 8.6.1 Latin America Active Implantable Medical Devices Market, by End User, 2022 - 2028 (USD Billion)
    • 8.7. The Middle-East and Africa
      • 8.7.5 The Middle-East and Africa Active Implantable Medical Devices Market, 2022 - 2028 (USD Billion)
        • 8.7.5.1 The Middle-East and Africa Active Implantable Medical Devices Market, by Country, 2022 - 2028 (USD Billion)
    • 8.4 The Middle-East and Africa Active Implantable Medical Devices Market, by Product, 2022 - 2028
      • 8.4.1 The Middle-East and Africa Active Implantable Medical Devices Market, by Product, 2022 - 2028 (USD Billion)
    • 8.5 The Middle-East and Africa Active Implantable Medical Devices Market, by Ventricular Assist Devices, 2022 - 2028
      • 8.5.1 The Middle-East and Africa Active Implantable Medical Devices Market, by Ventricular Assist Devices, 2022 - 2028 (USD Billion)
    • 8.6 The Middle-East and Africa Active Implantable Medical Devices Market, by End User, 2022 - 2028
      • 8.6.1 The Middle-East and Africa Active Implantable Medical Devices Market, by End User, 2022 - 2028 (USD Billion)
  • Chapter 9. Company Profiles
    • 9.1 Cardinal Health Inc.
      • 9.1.1 Overview
      • 9.1.2 Financials
      • 9.1.3 Product Portfolio
      • 9.1.4 Business Strategy
      • 9.1.5 Recent Developments
    • 9.2 C. R. Bard Inc.
      • 9.2.1 Overview
      • 9.2.2 Financials
      • 9.2.3 Product Portfolio
      • 9.2.4 Business Strategy
      • 9.2.5 Recent Developments
    • 9.3 Boston Scientific Corporation
      • 9.3.1 Overview
      • 9.3.2 Financials
      • 9.3.3 Product Portfolio
      • 9.3.4 Business Strategy
      • 9.3.5 Recent Developments
    • 9.4 Biotronik SE Co. KG
      • 9.4.1 Overview
      • 9.4.2 Financials
      • 9.4.3 Product Portfolio
      • 9.4.4 Business Strategy
      • 9.4.5 Recent Developments
    • 9.5 Abbott Laboratories
      • 9.5.1 Overview
      • 9.5.2 Financials
      • 9.5.3 Product Portfolio
      • 9.5.4 Business Strategy
      • 9.5.5 Recent Developments
    • 9.6 LivaNova PLC
      • 9.6.1 Overview
      • 9.6.2 Financials
      • 9.6.3 Product Portfolio
      • 9.6.4 Business Strategy
      • 9.6.5 Recent Developments
    • 9.7 Johnson and Johnson
      • 9.7.1 Overview
      • 9.7.2 Financials
      • 9.7.3 Product Portfolio
      • 9.7.4 Business Strategy
      • 9.7.5 Recent Developments
    • 9.8 Integra LifeSciences Holdings Corporation
      • 9.8.1 Overview
      • 9.8.2 Financials
      • 9.8.3 Product Portfolio
      • 9.8.4 Business Strategy
      • 9.8.5 Recent Developments
    • 9.9 Globus Medical Inc.
      • 9.9.1 Overview
      • 9.9.2 Financials
      • 9.9.3 Product Portfolio
      • 9.9.4 Business Strategy
      • 9.9.5 Recent Developments
    • 9.10 CONMED Corporation
      • 9.10.1 Overview
      • 9.10.2 Financials
      • 9.10.3 Product Portfolio
      • 9.10.4 Business Strategy
      • 9.10.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Active Implantable Medical Devices Market, 2022 - 2028 (USD Billion)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Active Implantable Medical Devices Market attractiveness, By Product
  • 6. Global Active Implantable Medical Devices Market attractiveness, By Ventricular Assist Devices
  • 7. Global Active Implantable Medical Devices Market attractiveness, By End User
  • 8. Global Active Implantable Medical Devices Market share by Product, 2022 and 2028 (USD Billion)
  • 9. Global Active Implantable Medical Devices Market by Cardiac Pacemakers, 2022 - 2028 (USD Billion)
  • 10. Global Active Implantable Medical Devices Market by Implantable Cardioverter Defibrillators (ICD), 2022 - 2028 (USD Billion)
  • 11. Global Active Implantable Medical Devices Market by Nerve Simulators, 2022 - 2028 (USD Billion)
  • 12. Global Active Implantable Medical Devices Market by Cochlear Implants, 2022 - 2028 (USD Billion)
  • 13. Global Active Implantable Medical Devices Market by Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 14. Global Active Implantable Medical Devices Market share by Ventricular Assist Devices, 2022 and 2028 (USD Billion)
  • 15. Global Active Implantable Medical Devices Market by Cardiovascular, 2022 - 2028 (USD Billion)
  • 16. Global Active Implantable Medical Devices Market by Neurological, 2022 - 2028 (USD Billion)
  • 17. Global Active Implantable Medical Devices Market by Hearing impairment, 2022 - 2028 (USD Billion)
  • 18. Global Active Implantable Medical Devices Market by Others, 2022 - 2028 (USD Billion)
  • 19. Global Active Implantable Medical Devices Market share by End User, 2022 and 2028 (USD Billion)
  • 20. Global Active Implantable Medical Devices Market by Hospitals, 2022 - 2028 (USD Billion)
  • 21. Global Active Implantable Medical Devices Market by Specialty Clinics, 2022 - 2028 (USD Billion)
  • 22. Global Active Implantable Medical Devices Market by Ambulatory Surgical Centers, 2022 - 2028 (USD Billion)
  • 23. Global Active Implantable Medical Devices Market share, by Region, 2022 and 2028
  • 24. North America Active Implantable Medical Devices Market, 2022 - 2028 (USD Billion)
  • 25. Europe Active Implantable Medical Devices Market, 2022 - 2028 (USD Billion)
  • 26. Asia Pacific Active Implantable Medical Devices Market, 2022 - 2028 (USD Billion)
  • 27. Latin America Active Implantable Medical Devices Market, 2022 - 2028 (USD Billion)
  • 28. The Middle-East and Africa Active Implantable Medical Devices Market, 2022 - 2028 (USD Billion)

Table Of Tables

  • 1. Global Active Implantable Medical Devices Market: Snapshot
  • 2. Drivers of the Active Implantable Medical Devices Market: impact analysis
  • 3. North America Active Implantable Medical Devices Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 4. North America Active Implantable Medical Devices Market revenue, By Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 5. North America Active Implantable Medical Devices Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 6. U.S. Active Implantable Medical Devices Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 7. U.S. Active Implantable Medical Devices Market revenue, By Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 8. U.S. Active Implantable Medical Devices Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 9. Canada Active Implantable Medical Devices Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 10. Canada Active Implantable Medical Devices Market revenue, By Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 11. Canada Active Implantable Medical Devices Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 12. Europe Active Implantable Medical Devices Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 13. Europe Active Implantable Medical Devices Market revenue, By Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 14. Europe Active Implantable Medical Devices Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 15. Germany Active Implantable Medical Devices Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 16. Germany Active Implantable Medical Devices Market revenue, By Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 17. Germany Active Implantable Medical Devices Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 18. France Active Implantable Medical Devices Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 19. France Active Implantable Medical Devices Market revenue, By Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 20. France Active Implantable Medical Devices Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 21. U.K. Active Implantable Medical Devices Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 22. U.K. Active Implantable Medical Devices Market revenue, By Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 23. U.K. Active Implantable Medical Devices Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 24. Italy Active Implantable Medical Devices Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 25. Italy Active Implantable Medical Devices Market revenue, By Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 26. Italy Active Implantable Medical Devices Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 27. Spain Active Implantable Medical Devices Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 28. Spain Active Implantable Medical Devices Market revenue, By Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 29. Spain Active Implantable Medical Devices Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 30. Rest of Europe Active Implantable Medical Devices Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 31. Rest of Europe Active Implantable Medical Devices Market revenue, By Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 32. Rest of Europe Active Implantable Medical Devices Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 33. Asia Pacific Active Implantable Medical Devices Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 34. Asia Pacific Active Implantable Medical Devices Market revenue, By Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 35. Asia Pacific Active Implantable Medical Devices Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 36. China Active Implantable Medical Devices Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 37. China Active Implantable Medical Devices Market revenue, By Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 38. China Active Implantable Medical Devices Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 39. Japan Active Implantable Medical Devices Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 40. Japan Active Implantable Medical Devices Market revenue, By Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 41. Japan Active Implantable Medical Devices Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 42. India Active Implantable Medical Devices Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 43. India Active Implantable Medical Devices Market revenue, By Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 44. India Active Implantable Medical Devices Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 45. South Korea Active Implantable Medical Devices Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 46. South Korea Active Implantable Medical Devices Market revenue, By Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 47. South Korea Active Implantable Medical Devices Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 48. South-East Asia Active Implantable Medical Devices Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 49. South-East Asia Active Implantable Medical Devices Market revenue, By Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 50. South-East Asia Active Implantable Medical Devices Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 51. Rest of Asia Pacific Active Implantable Medical Devices Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 52. Rest of Asia Pacific Active Implantable Medical Devices Market revenue, By Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 53. Rest of Asia Pacific Active Implantable Medical Devices Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 54. Latin America Active Implantable Medical Devices Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 55. Latin America Active Implantable Medical Devices Market revenue, By Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 56. Latin America Active Implantable Medical Devices Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 57. Brazil Active Implantable Medical Devices Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 58. Brazil Active Implantable Medical Devices Market revenue, By Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 59. Brazil Active Implantable Medical Devices Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 60. Mexico Active Implantable Medical Devices Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 61. Mexico Active Implantable Medical Devices Market revenue, By Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 62. Mexico Active Implantable Medical Devices Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 63. Rest of Latin America Active Implantable Medical Devices Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 64. Rest of Latin America Active Implantable Medical Devices Market revenue, By Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 65. Rest of Latin America Active Implantable Medical Devices Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 66. The Middle-East and Africa Active Implantable Medical Devices Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 67. The Middle-East and Africa Active Implantable Medical Devices Market revenue, By Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 68. The Middle-East and Africa Active Implantable Medical Devices Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 69. GCC Countries Active Implantable Medical Devices Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 70. GCC Countries Active Implantable Medical Devices Market revenue, By Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 71. GCC Countries Active Implantable Medical Devices Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 72. South Africa Active Implantable Medical Devices Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 73. South Africa Active Implantable Medical Devices Market revenue, By Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 74. South Africa Active Implantable Medical Devices Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 75. Rest of Middle-East Africa Active Implantable Medical Devices Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 76. Rest of Middle-East Africa Active Implantable Medical Devices Market revenue, By Ventricular Assist Devices, 2022 - 2028 (USD Billion)
  • 77. Rest of Middle-East Africa Active Implantable Medical Devices Market revenue, By End User, 2022 - 2028 (USD Billion)

Methodology

Free Analysis

Implantable medical devices are the type of medical devices that are partially or totally inserted into the human body with the help of medical intervention and are dedicated to remaining there after the procedure. They can support the damaged part, can replace the missing part of the human body or also modify the important function of the body.

According to the WHO (World Health Organization), around 17 million people die annually from cardiovascular diseases. According to the CDC (Centers for Disease Control and Prevention), in 2017, 2.7 to 6.1 million people were suffering from atrial fibrillation, a type of heart arrhythmia, in the U.S. Prevalence of neurological disorders such as epilepsy, Parkinson’s disease, and essential tremors, were reported to be high in emerging economies such as India. For instance, in the U.S. according to NIH (National Institute of Health), approximately 50,000 people suffer from Parkinson’s disease annually. This increase in the prevalence of cardiovascular diseases and neurological disorders has a positive impact on the growth of the global active implantable medical devices market. The high cost of implantable devices and the risks associated with the use of these devices is affecting the growth of the global market for active implantable medical devices.

Global Active Implantable Medical Devices Market

The active implantable medical devices market is segmented on the product, application, and end-user. Based on the product, the active implantable medical devices market is further segmented into cardiac pacemakers, implantable cardioverter defibrillators (ICD), nerve stimulators, cochlear implants, and ventricular assist devices. The cardiac pacemakers segment is further sub-segmented into single chamber pacemakers, dual chambers pacemakers, and others. Transvenous ICD and subcutaneous ICD are included in the implantable cardioverter defibrillators segment. Nerve stimulators segment includes deep brain stimulators, vagus nerve stimulators, sacral nerve stimulators, gastric electrical stimulators, and spinal cord stimulators. Implantable cardioverter defibrillator (ICD) is anticipated to dominate the market owing to the rapid development of advanced devices. Based on the application, the active implantable medical devices market is sub-segmented into cardiovascular, neurological, hearing impairment, and others. The cardiovascular segment is projected to dominate the active implantable medical devices market in the forecast period. The end-user segment of the active implantable medical devices market includes hospitals, specialty clinics, and ASCs. The hospital segment is expected to dominate the end-user segment due to the presence of a large patient pool in the hospitals. 

North America is anticipated to dominate the market in the forecast period due to the rise in the number of people suffering from arrhythmia and the early launch of technologically advanced products by companies in this region. In the forecast period, Asia Pacific is expected to follow North America and Europe due to an increase in the occurrence of cardiovascular diseases and arrhythmia because of the changing lifestyle and adoption of western culture. Also, the increase in investments and product launches by various companies and less stringent laws regarding implantable devices is expected to fuel the growth of the active implantable medical devices market.

The key players in the global market for active implantable medical devices are Boston Scientific Corp., Cochlear Ltd., LivaNova Plc., Medtronic Plc, Sonova Holding AG, Abbott Laboratories, Nurotron Biotechnology Co. Ltd., William Demant Holding A/S, MED-EL, and Biotronik SE. The company focuses on merger and acquisitions to develop new products with advanced technologies. For instance, in 2015, Cyberonics and Sorin Group merged to form LivaNova Plc. In April 2018, the subsidiaries of Terumo Corp. merged to expand its presence in the global aortic and vascular implants market.

Choose License Type

FrequentlyAsked Questions

Rising demand for active implantable medical devices is boosting the market growth. The need for active implantable devices has increased as the number of disorders and diseases has increased. These devices aid in the support or replacement of any injured bodily organs, as well as the enhancement and treatment of normal body functions. One of the most crucial aspects of patient care is an active implanted medical device.

According to the Zion Market Research report, the global active implantable medical devices market was worth about 85.31 (USD billion) in 2021 and is predicted to grow to around 143.10 (USD billion) by 2028, with a compound annual growth rate (CAGR) of around 6.60 percent.

North America is expected to hold the largest share of the global active implantable medical devices market, and this is expected to continue during the forecast period. The expanding demand for neurological and cardiovascular problems, as well as a rising focus on development and sophisticated and novel products, are expected to propel the North American market forward in the approaching years. Furthermore, rising healthcare expenditures and increased consumer awareness of the availability of effective treatments are expected to fuel market expansion in the near future.

The predominant players that are successfully functioning in the global active implantable medical devices market are Cardinal Health, Inc., C. R. Bard, Inc., Boston Scientific Corporation, Biotronik SE, and Co. KG, Abbott Laboratories, LivaNova PLC, Johnson and Johnson, Integra LifeSciences Holdings Corporation, Globus Medical, Inc., and CONMED Corporation, among others.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed